279 related articles for article (PubMed ID: 20095887)
41. Growth hormone, dehydroepiandrosterone and adiponectin levels in non-alcoholic steatohepatitis: an endocrine signature for advanced fibrosis in obese patients.
Koehler E; Swain J; Sanderson S; Krishnan A; Watt K; Charlton M
Liver Int; 2012 Feb; 32(2):279-86. PubMed ID: 22098614
[TBL] [Abstract][Full Text] [Related]
42. The role of chemerin in the pathogenesis of cholelithiasis in children and adolescents.
Zdanowicz K; Ryzko J; Bobrus-Chociej A; Wojtkowska M; Lebensztejn DM
J Paediatr Child Health; 2021 Mar; 57(3):371-375. PubMed ID: 33043555
[TBL] [Abstract][Full Text] [Related]
43. Circulating chemerin level is independently correlated with arterial stiffness.
Yoo HJ; Choi HY; Yang SJ; Kim HY; Seo JA; Kim SG; Kim NH; Choi KM; Choi DS; Baik SH
J Atheroscler Thromb; 2012; 19(1):59-66; discussion 67-8. PubMed ID: 22104178
[TBL] [Abstract][Full Text] [Related]
44. Serum homocysteine levels in patients with nonalcoholic fatty liver disease.
Polyzos SA; Kountouras J; Patsiaoura K; Katsiki E; Zafeiriadou E; Deretzi G; Zavos C; Gavalas E; Katsinelos P; Mane V; Slavakis A
Ann Hepatol; 2012; 11(1):68-76. PubMed ID: 22166563
[TBL] [Abstract][Full Text] [Related]
45. Circulating and Adipose Levels of Adipokines Associated With Insulin Sensitivity in Nonobese Subjects With Type 2 Diabetes.
Andersson DP; Laurencikiene J; Acosta JR; Rydén M; Arner P
J Clin Endocrinol Metab; 2016 Oct; 101(10):3765-3771. PubMed ID: 27501281
[TBL] [Abstract][Full Text] [Related]
46. Serum vaspin level as a predictive indicator in the amelioration of fatty liver and metabolic disturbance in patients with severe obesity after laparoscopic vertical banded gastroplasty.
Wang Y; Yu ZF; Cheng YS; Jia BL; Yu G; Yin XQ; Wang Y
Medicine (Baltimore); 2017 Jul; 96(30):e7498. PubMed ID: 28746192
[TBL] [Abstract][Full Text] [Related]
47. Chemerin is highly expressed in hepatocytes and is induced in non-alcoholic steatohepatitis liver.
Krautbauer S; Wanninger J; Eisinger K; Hader Y; Beck M; Kopp A; Schmid A; Weiss TS; Dorn C; Buechler C
Exp Mol Pathol; 2013 Oct; 95(2):199-205. PubMed ID: 23906870
[TBL] [Abstract][Full Text] [Related]
48. Circulating chemerin levels in metabolic-associated fatty liver disease: a systematic review and meta-analysis.
Ren Q; Wang H; Zeng Y; Fang X; Wang M; Li D; Huang W; Xu Y
Lipids Health Dis; 2022 Mar; 21(1):27. PubMed ID: 35236351
[TBL] [Abstract][Full Text] [Related]
49. Serum concentration of adiponectin, leptin and resistin in obese children with non-alcoholic fatty liver disease.
Lebensztejn DM; Wojtkowska M; Skiba E; Werpachowska I; Tobolczyk J; Kaczmarski M
Adv Med Sci; 2009; 54(2):177-82. PubMed ID: 20022856
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of circulating zonulin as a potential marker in the pathogenesis of nonalcoholic fatty liver disease.
Hendy OM; Elsabaawy MM; Aref MM; Khalaf FM; Oda AMA; El Shazly HM
APMIS; 2017 Jul; 125(7):607-613. PubMed ID: 28430371
[TBL] [Abstract][Full Text] [Related]
51. Chemerin as a marker of body fat and insulin resistance in women with polycystic ovary syndrome.
Kort DH; Kostolias A; Sullivan C; Lobo RA
Gynecol Endocrinol; 2015 Feb; 31(2):152-5. PubMed ID: 25295622
[TBL] [Abstract][Full Text] [Related]
52. Analysis of adipokine concentrations in paediatric non-alcoholic fatty liver disease.
Fitzpatrick E; Dew TK; Quaglia A; Sherwood RA; Mitry RR; Dhawan A
Pediatr Obes; 2012 Dec; 7(6):471-9. PubMed ID: 22962039
[TBL] [Abstract][Full Text] [Related]
53. [Correlation of serum omentin-1 and chemerin with gestational diabetes mellitus].
Pan BL; Ma RM
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Aug; 36(9):1231-1236. PubMed ID: 27687656
[TBL] [Abstract][Full Text] [Related]
54. Influence of insulin resistance and adipokines in the grade of steatosis of nonalcoholic fatty liver disease.
Aller R; de Luis DA; Fernandez L; Calle F; Velayos B; Olcoz JL; Izaola O; Sagrado MG; Conde R; Gonzalez JM
Dig Dis Sci; 2008 Apr; 53(4):1088-92. PubMed ID: 17934820
[TBL] [Abstract][Full Text] [Related]
55. Are serum chemerin levels different between obese and non-obese polycystic ovary syndrome women?
Yang S; Wang Q; Huang W; Song Y; Feng G; Zhou L; Tan J
Gynecol Endocrinol; 2016; 32(1):38-41. PubMed ID: 26291816
[TBL] [Abstract][Full Text] [Related]
56. Nonalcoholic steatohepatitis associated with metabolic syndrome: relationship to insulin resistance and liver histology.
Jung KY; Cho SY; Kim HJ; Kim SB; Song IH
J Clin Gastroenterol; 2014; 48(10):883-8. PubMed ID: 24440936
[TBL] [Abstract][Full Text] [Related]
57. Chronic ethanol consumption increases the levels of chemerin in the serum and adipose tissue of humans and rats.
Ren RZ; Zhang X; Xu J; Zhang HQ; Yu CX; Cao MF; Gao L; Guan QB; Zhao JJ
Acta Pharmacol Sin; 2012 May; 33(5):652-9. PubMed ID: 22447224
[TBL] [Abstract][Full Text] [Related]
58. Effects of rosiglitazone/metformin fixed-dose combination therapy and metformin monotherapy on serum vaspin, adiponectin and IL-6 levels in drug-naïve patients with type 2 diabetes.
Kadoglou NP; Kapelouzou A; Tsanikidis H; Vitta I; Liapis CD; Sailer N
Exp Clin Endocrinol Diabetes; 2011 Feb; 119(2):63-8. PubMed ID: 21031343
[TBL] [Abstract][Full Text] [Related]
59. Adipocytokines and cytokeratin-18 in patients with nonalcoholic fatty liver disease: Introduction of CHA index.
Polyzos SA; Kountouras J; Papatheodorou A; Katsiki E; Patsiaoura K; Zafeiriadou E; Papadopoulou E; Zavos C; Terpos E
Ann Hepatol; 2013; 12(5):749-57. PubMed ID: 24067262
[TBL] [Abstract][Full Text] [Related]
60. The Relationship between Insulin Resistance and Liver Damage in non-alcoholic Fatty Liver Patients.
Cetin EG; Demir N; Sen I
Sisli Etfal Hastan Tip Bul; 2020; 54(4):411-415. PubMed ID: 33364879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
